The on foreign companies for medicine and vaccines coupled with regulatory requirements has resulted in delays in delivery of vaccines to many African countries experiencing health emergencies. The WHO has been providing technical and financial support to countries to develop a national strategy for vaccine manufacturing. With the Mpox outbreak, the debate about domestic production has widened.